Importantly, inhibiting the GSDMD/Drp1 pathway effectively reverses neuronal injury, synaptic damage, and abnormalities in neural oscillations in the hippocampus of septic mice, thereby improving cognitive deficits. The gene discussed is DNM1L; the disease is Cognitive impairment.